Jump Trading’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-28,000
Closed -$1.55M 467
2018
Q2
$1.55M Buy
28,000
+3,500
+14% +$189K 0.12% 121
2018
Q1
$1.55M Buy
24,500
+21,600
+745% +$1.39M 0.15% 121
2017
Q4
$178K Sell
2,900
-10,600
-79% -$663K 0.02% 310
2017
Q3
$860K Sell
13,500
-1,500
-10% -$87.6K 0.16% 109
2017
Q2
$836K Buy
15,000
+10,600
+241% +$577K 0.12% 141
2017
Q1
$239K Buy
+4,400
New +$241K 0.08% 130
2016
Q3
Sell
-5,700
Closed -$419K 230
2016
Q2
$419K Buy
+5,700
New +$403K 0.02% 463
2016
Q1
Sell
-58
Closed -$399K 596
2015
Q4
$399K Sell
58
-55
-49% -$3.63K 0.01% 510
2015
Q3
$1.48M Sell
113
-4,087
-97% -$259K 0.02% 137
2015
Q2
$279K Buy
4,200
+500
+14% +$33K 0.01% 604
2015
Q1
$239K Sell
3,700
-21,700
-85% -$1.36M 0.01% 575
2014
Q4
$1.5M Buy
25,400
+18,200
+253% +$1.03M 0.04% 235
2014
Q3
$368K Sell
7,200
-7,400
-51% -$370K 0.01% 462
2014
Q2
$708K Buy
14,600
+8,500
+139% +$419K 0.03% 230
2014
Q1
$317K Sell
6,100
-30,400
-83% -$1.62M 0.01% 434
2013
Q4
$1.94M Buy
36,500
+17,800
+95% +$907K 0.18% 124
2013
Q3
$865K Buy
18,700
+3,800
+26% +$167K 0.14% 207
2013
Q2
$666K Buy
+14,900
New +$647K 0.26% 97

Other funds holding BMY

Jump Trading's BMY Position: Q2 2020 in Review

Jump Trading sold out of Bristol-Myers Squibb (BMY) in Q2 2020, closing a stake of 3,878 shares — an estimated $216K sold.

Jump Trading first reported a position in BMY in Q2 2013 and held it in 14 quarters. The position peaked at $786K in Q4 2019. 2,190 funds tracked by Wall St. Rank hold BMY as of Q2 2020.

  • Jump Trading reported no remaining Bristol-Myers Squibb position as of Q2 2020 after selling out during the quarter.
  • Jump Trading sold 3,878 Bristol-Myers Squibb shares in Q2 2020, an estimated $216K.
  • Jump Trading first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 14 quarters.
  • Jump Trading's Bristol-Myers Squibb position peaked at $786K in Q4 2019.
  • 2,190 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2020.

Based on Jump Trading's 13F filing for Q2 2020, filed 3 Aug 2020.